Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Amano

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 9, 2016
Possible assessment of coagulation function and haemostasis therapy using comprehensive coagulation assays in a patient with acquired haemophilia AM Takeyama, K Nogami, T Matsumoto, et al.
Rinsho Hoshasen. Clinical Radiography|July 1, 1984
[A case report of histologically proven reactive lymphoreticular hyperplasia (RLH) of the cecum]T Ueno, T Fujimoto, G Yamaguchi, et al.
Biochemical and Biophysical Research Communications|October 4, 1995
Relationship between susceptibility to apoptosis and Fas expression in peripheral blood T cells from uremic patients: a possible mechanism for lymphopenia in chronic renal failureY Matsumoto, T Shinzato, I Amano, et al.
Journal of Biochemistry|June 19, 1998
Increased serum midkine levels during hemodialysis using heparin in chronic renal failureK Fujisawa, Y Matsumoto, H Muramatsu, et al.
Biochemistry. Biokhimiia|January 1, 1997
Structural and serological studies of the O-antigen of the bacterium Proteus mirabilis OXK (serogroup O3) used in the Weil-Felix testA S Swierzko, M Cedzynski, Knirel YuA, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 26, 1998
Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patientsY Sakurauchi, Y Matsumoto, T Shinzato, et al.
FEBS Letters|July 14, 1997
Structures of the O-antigens of Proteus bacilli belonging to OX group (serogroups O1-O3) used in Weil-Felix testA Ziolkowski, A S Shashkov, A S Swierzko, et al.
Nihon Jinzo Gakkai Shi|June 1, 1981
[A case study of tuberous sclerosis with subdural hematoma (author's transl)]Y Inagaki, T Yamamoto, K Tsuzuki, et al.
Biochemistry. Biokhimiia|May 1, 1997
Structure of the acid-labile galactosyl phosphate-containing O-antigen of the bacterium Proteus vulgaris OX19 (serogroup O1) used in the Weil-Felix testS N Senchenkova, A S Shashkov, F V Toukach, et al.
World Journal of Surgery|June 9, 2001
Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 activities in septic patientsT Tani, K Hanasawa, M Kodama, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 9, 2016
Possible assessment of coagulation function and haemostasis therapy using comprehensive coagulation assays in a patient with acquired haemophilia AM Takeyama, K Nogami, T Matsumoto, et al.
Rinsho Hoshasen. Clinical Radiography|July 1, 1984
[A case report of histologically proven reactive lymphoreticular hyperplasia (RLH) of the cecum]T Ueno, T Fujimoto, G Yamaguchi, et al.
Biochemical and Biophysical Research Communications|October 4, 1995
Relationship between susceptibility to apoptosis and Fas expression in peripheral blood T cells from uremic patients: a possible mechanism for lymphopenia in chronic renal failureY Matsumoto, T Shinzato, I Amano, et al.
Journal of Biochemistry|June 19, 1998
Increased serum midkine levels during hemodialysis using heparin in chronic renal failureK Fujisawa, Y Matsumoto, H Muramatsu, et al.
Biochemistry. Biokhimiia|January 1, 1997
Structural and serological studies of the O-antigen of the bacterium Proteus mirabilis OXK (serogroup O3) used in the Weil-Felix testA S Swierzko, M Cedzynski, Knirel YuA, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 26, 1998
Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patientsY Sakurauchi, Y Matsumoto, T Shinzato, et al.
FEBS Letters|July 14, 1997
Structures of the O-antigens of Proteus bacilli belonging to OX group (serogroups O1-O3) used in Weil-Felix testA Ziolkowski, A S Shashkov, A S Swierzko, et al.
Nihon Jinzo Gakkai Shi|June 1, 1981
[A case study of tuberous sclerosis with subdural hematoma (author's transl)]Y Inagaki, T Yamamoto, K Tsuzuki, et al.
Biochemistry. Biokhimiia|May 1, 1997
Structure of the acid-labile galactosyl phosphate-containing O-antigen of the bacterium Proteus vulgaris OX19 (serogroup O1) used in the Weil-Felix testS N Senchenkova, A S Shashkov, F V Toukach, et al.
World Journal of Surgery|June 9, 2001
Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 activities in septic patientsT Tani, K Hanasawa, M Kodama, et al.
Pageof 7